2011
DOI: 10.1021/nl2015872
|View full text |Cite
|
Sign up to set email alerts
|

Detection of Multiple Disease Indicators by an Autonomous Biomolecular Computer

Abstract: The promise of biomolecular computers is their ability to interact with naturally occurring biomolecules, enabling in the future the development of context-dependent programmable drugs. Here we show a context-sensing mechanism of a biomolecular automaton that can simultaneously sense different types of molecules, allowing future integration of biomedical knowledge on a broad range of molecular disease symptoms in the decision of a biomolecular computer to release a drug molecule.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
34
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(34 citation statements)
references
References 59 publications
(98 reference statements)
0
34
0
Order By: Relevance
“…[43] Moreover, logical circuitry may one day lead to the development of “smart drugs” that can sense and analyze multiple physiological cues and then perform logical operations to release drugs or regulate genetic expressions. [44] Another direction includes mimicking biological systems by using dynamic NA-based devices to gain more insight into naturally occurring systems, with concomitant translational applications, for example, in the design of artificial neural networks exhibiting autonomous brainlike behaviors. [11] It is difficult to predict how far these NA-based logical systems can go, as new technologies will continue to emerge.…”
Section: Discussionmentioning
confidence: 99%
“…[43] Moreover, logical circuitry may one day lead to the development of “smart drugs” that can sense and analyze multiple physiological cues and then perform logical operations to release drugs or regulate genetic expressions. [44] Another direction includes mimicking biological systems by using dynamic NA-based devices to gain more insight into naturally occurring systems, with concomitant translational applications, for example, in the design of artificial neural networks exhibiting autonomous brainlike behaviors. [11] It is difficult to predict how far these NA-based logical systems can go, as new technologies will continue to emerge.…”
Section: Discussionmentioning
confidence: 99%
“…81 Drug-releasing processes triggered by biomolecular signals are of special interest and are promising for functional integration of releasing systems with physiological processes, 82 particularly for development of closed-loop control systems. 83 Processing different biomolecular signals using biocomputing logic systems will result in "smart" autonomously operating molecular devices 84 In most of the presently designed substance-releasing systems activated by biochemical signals, the sensing component is represented by chemical receptors directly integrated with the releasing system, 85 significantly increasing the system complexity and limiting its versatility. The system design would be much easier if the sub-systems responsible for the signal-processing and signaltriggered drug release were realized in different materials, essentially on different electrodes, communicating electrically.…”
Section: Integration Of Bioelectrochemical Actuators With Biomoleculamentioning
confidence: 99%
“…The design and construction of molecular computers with small size and lower power consumption can help us to process, transfer, and store information at the molecular level and further understand life processes and activities [1][2][3][4][5]. Molecular computers have much computing performance that may be hard to reach with silicon-based devices.…”
Section: Introductionmentioning
confidence: 99%